Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Piris

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Leukemia|December 4, 2013
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiationN Martínez, C Almaraz, J P Vaqué, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
The British Journal of Dermatology|May 4, 2019
Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathwaysC Pérez, R Mondéjar, N García-Díaz, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Leukemia|March 23, 2012
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyC Visco, Y Li, Z Y Xu-Monette, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2011
Clinical and molecular characterization of diffuse large B-cell lymphomas with 13q14.3 deletionM Mian, M Scandurra, E Chigrinova, et al.
Leukemia|July 27, 2017
Concordant bone marrow involvement of diffuse large B-cell lymphoma represents a distinct clinical and biological entity in the era of immunotherapyZ Yao, L Deng, Z Y Xu-Monette, et al.
Histopathology|July 18, 2002
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 casesS A Pileri, T M Grogan, N L Harris, et al.
Leukemia|December 4, 2013
Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiationN Martínez, C Almaraz, J P Vaqué, et al.
Leukemia|August 27, 2015
Primary testicular diffuse large B-cell lymphoma displays distinct clinical and biological features for treatment failure in rituximab era: a report from the International PTL ConsortiumL Deng, Z Y Xu-Monette, S Loghavi, et al.
The British Journal of Dermatology|May 4, 2019
Advanced-stage mycosis fungoides: role of the signal transducer and activator of transcription 3, nuclear factor-κB and nuclear factor of activated T cells pathwaysC Pérez, R Mondéjar, N García-Díaz, et al.
Leukemia|August 30, 2016
Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphomaY Xia, Z Y Xu-Monette, A Tzankov, et al.
Leukemia|March 23, 2012
Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program StudyC Visco, Y Li, Z Y Xu-Monette, et al.
Pageof 12